Alterations in peripheral blood B cell subsets and their clinical significance in systemic lupus erythematosus

Key Points

• Alterations in peripheral blood B cell subsets correlate with disease severity in systemic lupus erythematosus.
• Key evidence shows significant changes in various B cell populations among affected individuals, indicating their role as biomarkers.
• Observational analysis assessed immune responses across multiple patient cohorts and linked B cell subset variation to disease activity.
• Highlights the importance of identifying B cell subsets as potential therapeutic targets in systemic lupus erythematosus management.